Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Journal of the American Chemical Society|July 11, 2002
Elastic deformation of membrane bilayers probed by deuterium NMR relaxationMichael F Brown, Robin L Thurmond, Steven W Dodd, et al.Journal of Drugs in Dermatology : JDD|August 21, 2018
Efficacy and Safety of Toreforant, a Selective Histamine H4 Receptor Antagonist, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled TrialEllen Frankel, Michael Song, Shu Li, et al.The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cellsClaudia L Hofstra, Pragnya J Desai, Robin L Thurmond, et al.Biochemistry|May 16, 2002
Conformational energetics of rhodopsin modulated by nonlamellar-forming lipidsAna Vitória Botelho, Nicholas J Gibson, Robin L Thurmond, et al.Annals of the New York Academy of Sciences|July 15, 2005
The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiencyDavid Naor, Shlomo Nedvetzki, Nathalie Assayag, et al.Cell Biology International|July 6, 2007
Histamine H4 receptor expression is elevated in human nasal polyp tissueAdrienn Jókúti, Eva Hellinger, Andrea Hellinger, et al.Respiratory Research|June 25, 2010
Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokinesJeffery M Cowden, Jason P Riley, Jing Ying Ma, et al.Biophysical Journal|September 11, 2022
Phospholipid headgroups govern area per lipid and emergent elastic properties of bilayersTrivikram R Molugu, Robin L Thurmond, Todd M Alam, et al.The Journal of Allergy and Clinical Immunology|January 9, 2007
Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritusPaul J Dunford, Kacy N Williams, Pragnya J Desai, et al.Recent Patents on Inflammation & Allergy Drug Discovery|December 19, 2009
Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune diseaseJennifer D Venable, Michael K Ameriks, Jonathan M Blevitt, et al.Pageof 8